A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
Phase of Trial: Phase III
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Defibrotide (Primary)
- Indications Veno-occlusive disorders
- Focus Registrational; Therapeutic Use
- Sponsors Jazz Pharmaceuticals Inc
- 28 Feb 2017 According to Jazz Pharmaceuticals media release, first patient has been enrolled in this study in January 2017.
- 28 Sep 2016 Status changed from not yet recruiting to recruiting.
- 03 Aug 2016 New trial record